BACKGROUND: In 2011, the Medicare Improvements for Patients and Providers Act replaced the case-mix-adjusted composite payment system for Medicare outpatient dialysis facilities with a bundled end-stage renal disease prospective payment system (PPS). We assessed the economic implications for modality choice of the revised Medicare payment system. STUDY DESIGN: Microeconomic analyses. SETTING & POPULATION: Patients eligible for dialysis in the United States. MODEL, PERSPECTIVE, & TIMEFRAME: The perspective of this analysis is that of a financial administrator of a representative dialysis center in the United States. Data were obtained from the Medicare Payment Advisory Commission, the US Renal Data System, the DOPPS (Dialysis Outcomes and Practice Patterns Study) Practice Monitor, the US Bureau of Labor Statistics, and Medicare fee schedules. INTERVENTIONS: Recently implemented end-stage renal disease PPS versus the prior case-mix composite payment system. OUTCOMES: Medicare payment per month, center fixed and variable costs per month, net difference in revenue and variable costs (direct contribution), and net difference in revenue and total costs (operating margin). RESULTS: The direct contribution and operating margin for in-center hemodialysis and peritoneal dialysis are expected to be positive under the new bundled PPS. For Medicare fiscal intermediaries/administrators, paid treatments for home hemodialysis vary from 3.2 to more than 4.8 per week. The direct contribution and operating margin are expected to be negative for home hemodialysis if the number of paid treatments is similar between in-center and home hemodialysis; they are almost identical when the number of paid treatments increases for home hemodialysis by approximately 1 per week. LIMITATIONS: Experience across centers and intermediaries/administrators may vary. Sensitivity analyses were conducted to assess the robustness of findings and determine which variables most influenced results. CONCLUSIONS: The new bundled PPS created a financial incentive for increased use of peritoneal dialysis. Use of home hemodialysis may be influenced by number of paid treatments per week.
BACKGROUND: In 2011, the Medicare Improvements for Patients and Providers Act replaced the case-mix-adjusted composite payment system for Medicare outpatient dialysis facilities with a bundled end-stage renal disease prospective payment system (PPS). We assessed the economic implications for modality choice of the revised Medicare payment system. STUDY DESIGN: Microeconomic analyses. SETTING & POPULATION: Patients eligible for dialysis in the United States. MODEL, PERSPECTIVE, & TIMEFRAME: The perspective of this analysis is that of a financial administrator of a representative dialysis center in the United States. Data were obtained from the Medicare Payment Advisory Commission, the US Renal Data System, the DOPPS (Dialysis Outcomes and Practice Patterns Study) Practice Monitor, the US Bureau of Labor Statistics, and Medicare fee schedules. INTERVENTIONS: Recently implemented end-stage renal disease PPS versus the prior case-mix composite payment system. OUTCOMES: Medicare payment per month, center fixed and variable costs per month, net difference in revenue and variable costs (direct contribution), and net difference in revenue and total costs (operating margin). RESULTS: The direct contribution and operating margin for in-center hemodialysis and peritoneal dialysis are expected to be positive under the new bundled PPS. For Medicare fiscal intermediaries/administrators, paid treatments for home hemodialysis vary from 3.2 to more than 4.8 per week. The direct contribution and operating margin are expected to be negative for home hemodialysis if the number of paid treatments is similar between in-center and home hemodialysis; they are almost identical when the number of paid treatments increases for home hemodialysis by approximately 1 per week. LIMITATIONS: Experience across centers and intermediaries/administrators may vary. Sensitivity analyses were conducted to assess the robustness of findings and determine which variables most influenced results. CONCLUSIONS: The new bundled PPS created a financial incentive for increased use of peritoneal dialysis. Use of home hemodialysis may be influenced by number of paid treatments per week.
Authors: Eric W Young; Alissa Kapke; Zhechen Ding; Regina Baker; Jeffrey Pearson; Chad Cogan; Purna Mukhopadhyay; Marc N Turenne Journal: Clin J Am Soc Nephrol Date: 2019-09-12 Impact factor: 8.237
Authors: Virginia Wang; Cynthia J Coffman; Linda L Sanders; Shoou-Yih D Lee; Richard A Hirth; Matthew L Maciejewski Journal: Clin J Am Soc Nephrol Date: 2018-11-19 Impact factor: 8.237
Authors: Virginia Wang; Matthew L Maciejewski; Cynthia J Coffman; Linda L Sanders; Shoou-Yih Daniel Lee; Richard Hirth; Joseph Messana Journal: Health Serv Res Date: 2016-04-07 Impact factor: 3.402
Authors: Caroline E Sloan; Cynthia J Coffman; Linda L Sanders; Matthew L Maciejewski; Shoou-Yih D Lee; Richard A Hirth; Virginia Wang Journal: Clin J Am Soc Nephrol Date: 2019-11-21 Impact factor: 8.237
Authors: Adam S Wilk; Richard A Hirth; Wei Zhang; John R C Wheeler; Marc N Turenne; Tammie A Nahra; Kathryn K Sleeman; Joseph M Messana Journal: Health Serv Res Date: 2017-01-19 Impact factor: 3.734
Authors: Jenny I Shen; Kevin F Erickson; Lucia Chen; Sitaram Vangala; Lynn Leng; Anuja Shah; Anjali B Saxena; Jeffrey Perl; Keith C Norris Journal: Clin J Am Soc Nephrol Date: 2019-07-18 Impact factor: 10.614